HIGHLIGHTS
- What: This study investigated and peripheral dopaminergic makers in schizophrenia and their relationship with cognitive impairment.
- Who: Yuan-Hwa Chou and colleagues from the Department of Psychiatry, Taipei Veterans General Hospital, Taipei, TaiwanMedicine, National Ming Chiao Tung University, Taipei, Taiwan have published the Article: Psychological Medicine Original Article, in the Journal: (JOURNAL)
- How: The authors implemented a two-step analytical approach to address potential group differences in these relationships (Yang et_al 2021).
- Future: Future research focused on drug-naive patients is warranted to replicate the findings . Nonetheless future studies should apply . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.